1 result(s) for
|PI Name||Protocol #||Title|
|Eric Anderson||STUDY00017574||A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Somatic Mutations Detected in Blood (B-FAST: Blood-First Assay Screening Trial|
You may also qualify for Phase 1 Program trials.
For more information: